No. of Recommendations: 9
In Texas, a striking hostility to medication abortion and the FDA's approach
Besides pausing his ruling for one week, Kacsmaryk ' an appointee of former President Donald Trump who sits in Amarillo, Texas ' seemed to hold nothing back as he ripped apart the FDA's approval of mifepristone and embraced wholeheartedly the challengers' arguments that the drug's risks weren't adequately considered.
===========================
So the anti abortion activists are all of a sudden concerned about women's health. The women may be taking risks because of inadequacies in the FDA's approval twenty years ago.
We know that that is not the activists real reason but the court has to consider what was put before them.
Lets say, the FDA did take a short cut. If that was last year, then maybe suspending the use of the drug would make sense. But since there is twenty years of actual use which has demonstrated safety, that is better data than any trial the FDA could have performed. So I just don't see how a judge could reasonably rule that the drug should be withdrawn regardless of the FDA's performance twenty years ago.
